Cargando…
Deletion of sphingosine kinase 1 inhibits liver tumorigenesis in diethylnitrosamine-treated mice
Primary liver cancer is the 3rd leading cause of cancer deaths worldwide with very few effective treatments. Sphingosine kinase 1 (SphK1), a key regulator of sphingolipid metabolites, is over-expressed in human hepatocellular carcinoma (HCC) and our previous studies have shown that SphK1 is importan...
Autores principales: | Chen, Jinbiao, Qi, Yanfei, Zhao, Yang, Kaczorowski, Dominik, Couttas, Timothy A., Coleman, Paul R., Don, Anthony S., Bertolino, Patrick, Gamble, Jennifer R., Vadas, Mathew A., Xia, Pu, McCaughan, Geoffrey W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884653/ https://www.ncbi.nlm.nih.gov/pubmed/29643998 http://dx.doi.org/10.18632/oncotarget.24583 |
Ejemplares similares
-
Novel miRNA-based drug CD5-2 reduces liver tumor growth in diethylnitrosamine-treated mice by normalizing tumor vasculature and altering immune infiltrate
por: Liu, Ken, et al.
Publicado: (2023) -
Regulation of hepatic insulin signaling and glucose homeostasis by sphingosine kinase 2
por: Aji, Gulibositan, et al.
Publicado: (2020) -
A Novel Function of Sphingosine Kinase 2 in the Metabolism of Sphinga-4,14-Diene Lipids
por: Couttas, Timothy Andrew, et al.
Publicado: (2020) -
Ablation of sphingosine kinase 2 suppresses fatty liver-associated hepatocellular carcinoma via downregulation of ceramide transfer protein
por: Liu, Xin Tracy, et al.
Publicado: (2022) -
The effects of markedly raised intracellular sphingosine kinase-1 activity in endothelial cells
por: Limaye, Vidya, et al.
Publicado: (2009)